WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H125048
CAS#: N/A
Description: DJ4 (EX-A7863) is a potent, selective ATP-competitive inhibitor of ROCK1/2 and MRCKα/β.
Hodoodo Cat#: H125048
Name: DJ4
CAS#: N/A
Chemical Formula: C19H18N4OS
Exact Mass: 350.12
Molecular Weight: 350.440
Elemental Analysis: C, 65.12; H, 5.18; N, 15.99; O, 4.57; S, 9.15
Synonym: DJ4; D-J4; D J4; EX-A7863; EXA7863; EX A7863; NSC781419; NSC781773; NSC-781419
IUPAC/Chemical Name: (2E,5Z)-5-((3a,7a-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-2-(phenethylimino)thiazolidin-4-one
InChi Key: LPLHRXWGAXZZJU-WJDWOHSUSA-N
InChi Code: InChI=1S/C19H18N4OS/c24-18-16(11-14-12-22-17-15(14)7-4-9-20-17)25-19(23-18)21-10-8-13-5-2-1-3-6-13/h1-7,9,11-12,15,17,22H,8,10H2,(H,21,23,24)/b16-11-
SMILES Code: O=C(/C(S/1)=C/C2=CNC3N=CC=CC23)NC1=N/CCC4=CC=CC=C4
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 350.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Golla U, Ehudin MA, Annageldiyev C, Zeng Z, Bastihalli Tukaramrao D, Tarren
A, Date AA, Elcheva I, Berg A, Amin S, Loughran TP Jr, Kester M, Desai D, Dovat
S, Claxton D, Sharma A. DJ4 Targets the Rho-Associated Protein Kinase Pathway
and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid
Leukemia. Cancers (Basel). 2021 Sep 29;13(19):4889. doi:
10.3390/cancers13194889. PMID: 34638385; PMCID: PMC8508452.
2: Abdul KM, Terada K, Gotoh T, Hafizur RM, Mori M. Characterization and
functional analysis of a heart-enriched DnaJ/ Hsp40 homolog dj4/DjA4. Cell
Stress Chaperones. 2002 Apr;7(2):156-66. doi:
10.1379/1466-1268(2002)007<0156:cafaoa>2.0.co;2. PMID: 12380683; PMCID:
PMC514813.
3: Kale VP, Hengst JA, Sharma AK, Golla U, Dovat S, Amin SG, Yun JK, Desai DH.
Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective
Inhibitor of ROCK and MRCK Kinases. Pharmaceuticals (Basel). 2023 Jul
26;16(8):1060. doi: 10.3390/ph16081060. PMID: 37630974; PMCID: PMC10458458.